UK markets open in 42 minutes
NIKKEI 225
39,539.12 +197.58 (+0.50%) HANG SENG
17,767.02 +50.55 (+0.29%) CRUDE OIL
82.26 +0.52 (+0.64%) GOLD FUTURES
2,336.80 +0.20 (+0.01%) DOW
39,164.06 +36.26 (+0.09%) Bitcoin GBP
48,688.68 +699.97 (+1.46%)
NVAX Jun 2024 10.500 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 12:31PM EDT. Market open.
| Previous close | 3.6500 |
| Open | 3.6500 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 10.50 |
| Expiry date | 2024-06-28 |
| Day's range | 3.6500 - 3.6500 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
Investor's Business DailyThe FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Novavax stock has pulled back after hitting a nearly two-year high earlier this month. Is NVAX stock a buy right now?
GuruFocus.comInsider Sale: Director James Young Sells Shares of Novavax Inc (NVAX)
The transaction was documented in a recent SEC Filing. Following this sale, the insider now owns 61,760 shares of Novavax Inc. Novavax Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative vaccines to prevent serious infectious diseases.
ZacksNovavax (NVAX) Seeks Nod for Updated COVID-19 Jab in Europe
Novavax (NVAX) seeks marketing authorization in the European Union for an updated version of its COVID-19 vaccine, which has been formulated to target the JN.1 variant.
© 2024 Yahoo. All rights reserved.